capecitabine

You have access
Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN and CHEN YU

Anticancer Research January 2025, 45 (1) 399-404; DOI: https://doi.org/10.21873/anticanres.17428
You have access
Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer
HIROSHI DOI, MASAYUKI FUJIWARA, NAOHITO BEPPU, HIROYUKI YOKOYAMA, SHOGO HARUI, AYAKO SUGIHARA, HIDENORI YANAGI, YOSHIO HISHIKAWA, NAOKI YAMANAKA and NORIHIKO KAMIKONYA

Anticancer Research November 2022, 42 (11) 5587-5595; DOI: https://doi.org/10.21873/anticanres.16066
You have access
Effectiveness of Hyperthermia as Monotherapy and Adjuvant Therapy Approaches Against an In Vitro Model of Colorectal Carcinoma
GEORGIOS PETRAKIS, THEODORA MANTSO, MICHAIL I. KOUKOURAKIS, MIHALIS I. PANAYIOTIDIS and SOTIRIS BOTAITIS

Anticancer Research May 2022, 42 (5) 2363-2374; DOI: https://doi.org/10.21873/anticanres.15715
You have access
Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study
MIHO TAKEMURA, KENJI IKEMURA, TETSUHIRO YOSHINAMI, YUJI TOYOZUMI, TAKUYA SHINTANI, MIKIKO UEDA, KENZO SHIMAZU and MASAHIRO OKUDA

Anticancer Research May 2022, 42 (5) 2591-2598; DOI: https://doi.org/10.21873/anticanres.15737
Open Access
Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI

Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
Open Access
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA

Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
You have access
Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin
EO JIN KIM, MOONHO KIM, SEYOUNG SEO, MI-JUNG KIM, MIN JU KIM and SOOK RYUN PARK

Anticancer Research January 2021, 41 (1) 391-402; DOI: https://doi.org/10.21873/anticanres.14788
You have access
Current Status of Therapeutic Drug Monitoring of 5-Fluorouracil Prodrugs
YASUHIRO HASHIMOTO, YOICHIRO YOSHIDA, TEPPEI YAMADA, NAOYA AISU, GUMPEI YOSHIMATSU, FUMIHIRO YOSHIMURA and SUGURU HASEGAWA

Anticancer Research August 2020, 40 (8) 4655-4661; DOI: https://doi.org/10.21873/anticanres.14464
You have access
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI

Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
You have access
Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling
JAE JUN SIM, MIN HEE PARK, JEONG-HEUM BAEK, HAEJUN LEE, KEUN-YEONG JEONG and HWAN MOOK KIM

Anticancer Research August 2018, 38 (8) 4667-4676; DOI: https://doi.org/10.21873/anticanres.12772

Main menu

User menu

Search

capecitabine

Pages